TLR4 and inflammation: Furthermore, recent evidences have shown that TLR4-mediated pathway can promote tubulointerstitial inflammation in DN, and TLR4 antagonist may slow the progression of DN by attenuating renal tubulointerstitial inflammation [15–18].